Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
3520 ARTÍCULOS , VIENDO DEL 1756 AL 1770
Dihydropyridine calcium channel blockers and the progression of parkinsonism
Marras C, Gruneir A, Rochon P, Wang X, Anderson G, Brotchie J, Bell CM, Fox S, Austin PC.
Ann Neurol. 2012 Mar;71(3):362-9. doi: 10.1002/ana.22616.
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2
Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T; PD GWAS Consortium.
Ann Neurol. 2012 Mar;71(3):370-84. doi: 10.1002/ana.22687.
The neuropathology of genetic Parkinson's disease
Poulopoulos M, Levy OA, Alcalay RN.
Mov Disord. 2012 Jun;27(7):831-42. doi: 10.1002/mds.24962. Epub 2012 Mar 26.
Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples
Marras C, Lohmann K, Lang A, Klein C.
Neurology. 2012 Mar 27;78(13):1016-24. doi: 10.1212/WNL.0b013e31824d58ab.
Use of the Gait Deviation index for the evaluation of patients with Parkinson's disease
Galli M, Cimolin V, De Pandis MF, Schwartz MH, Albertini G.
J Mot Behav. 2012;44(3):161-7. doi: 10.1080/00222895.2012.664180. Epub 2012 Mar 28.
Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies
Mimeault M, Batra SK.
Adv Exp Med Biol. 2012;741:171-86. doi: 10.1007/978-1-4614-2098-9_12.
Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons
Ungless MA, Grace AA.
Trends Neurosci. 2012 Jul;35(7):422-30. doi: 10.1016/j.tins.2012.02.003. Epub 2012 Mar 28.
Activity enhances dopaminergic long-duration response in Parkinson disease
Kang UJ, Auinger P; Parkinson Study Group ELLDOPA Investigators.
Neurology. 2012 Apr 10;78(15):1146-9. doi: 10.1212/WNL.0b013e31824f8056. Epub 2012 Mar 28.
The molecular basis of dopaminergic brain imaging in Parkinson's disease
Seibyl J, Russell D, Jennings D, Marek K.
Q J Nucl Med Mol Imaging. 2012 Feb;56(1):4-16.
The role of molecular imaging in the differential diagnosis of parkinsonism
Booij J, Teune LK, Verberne HJ.
Q J Nucl Med Mol Imaging. 2012 Feb;56(1):17-26.
Identification of biomarkers in Lewy-body disorders
Warr L, Walker Z.
Q J Nucl Med Mol Imaging. 2012 Feb;56(1):39-54.
Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging
Arnaldi D, Morbelli S, Morrone E, Campus C, Nobili F.
Q J Nucl Med Mol Imaging. 2012 Feb;56(1):55-67.
Steffen T, Petersen C, Dvorak L.
J Geriatr Phys Ther. 2012 Oct-Dec;35(4):173-80. doi: 10.1519/JPT.0b013e31824a1c9d.
Electrochemical determination of glutathione: a review
Harfield JC, Batchelor-McAuley C, Compton RG.
Analyst. 2012 May 21;137(10):2285-96. doi: 10.1039/c2an35090d. Epub 2012 Mar 29.
5-3’-[(18)F]Fluoropropyl-3-[2-((S)-pyrrolidinyl)methoxy]pyridine
Leung K.
2006 Sep 18 [updated 2012 Apr 3]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.